We are live on ! Find out more
AERI

Aerie Pharmaceuticals
AERI

Delisted

AERI was delisted on the 18th of November, 2022.

Back to rankings

148 hedge funds and large institutions have $552M invested in Aerie Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 50 increasing their positions, 50 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

101% more call options, than puts

Call options by funds: $1.26M | Put options by funds: $627K

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more repeat investments, than reductions

Existing positions increased: 50 | Existing positions reduced: 50

5% less funds holding

Funds holding: 155 → 148 (-7)

23% less capital invested

Capital invested by funds: $712M → $552M (-$160M)

27% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 22

Holders
148
Holders Change
-7
Holders Change %
-4.52%
% of All Funds
2.99%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
16
Increased
50
Reduced
50
Closed
22
Calls
$1.26M
Puts
$627K
Net Calls
+$635K
Net Calls Change
+$1.36M

Top Buyers

Rank Fund Capital Flow
1
CWG
C WorldWide Group
Denmark
+$11M
2
Loomis, Sayles & Company
Loomis, Sayles & Company
Massachusetts
+$9.08M
3
Goldman Sachs
Goldman Sachs
New York
+$8.33M
4
Bank of America
Bank of America
North Carolina
+$5.55M
5
Ameriprise
Ameriprise
Minnesota
+$3.36M

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$10.4M
2
FAM
Fred Alger Management
New York
-$9.68M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
-$8.12M
4
Handelsbanken Fonder
Handelsbanken Fonder
Sweden
-$6.5M
5
LCS
Levin Capital Strategies
New York
-$4.87M
Name Holding Trade Value Shares
Change 		Change in
Stake
GT
126
Glenmede Trust
Pennsylvania
$33K +$2.06K +169 +6%
EWM
127
Endurance Wealth Management
Rhode Island
$28K -$2.44K -200 -8%
Royal Bank of Canada
128
Royal Bank of Canada
Ontario, Canada
$27K -$1.64K -135 -5%
BCV
129
Banque Cantonale Vaudoise
Switzerland
$27K +$27.4K +2,252 New
PHK
130
Point72 Hong Kong
Hong Kong
$22K -$19.5K -1,597 -47%
Bank of Montreal
131
Bank of Montreal
Ontario, Canada
$20K -$15.1K -1,236 -42%
US Bancorp
132
US Bancorp
Minnesota
$16K +$13.9K +1,138 +662%
GRP
133
Global Retirement Partners
California
$10K – – –
Rockefeller Capital Management
134
Rockefeller Capital Management
New York
$5K +$2.03K +167 +58%
LJHT
135
Laurie J. Hall Trustee
$5K +$4.87K +400 New
PCM
136
Penserra Capital Management
California
$4K +$4.82K +396 New
Carson Wealth (CWM LLC)
137
Carson Wealth (CWM LLC)
Nebraska
$3K – – –
Daiwa Securities Group
138
Daiwa Securities Group
Japan
$3K – – –
LC
139
Lindbrook Capital
California
$3K +$3.01K +247 New
MCM
140
Manchester Capital Management
Vermont
$2K – – –
PNC Financial Services Group
141
PNC Financial Services Group
Pennsylvania
$2K – – –
SFS
142
Sowell Financial Services
Arkansas
$2K +$341 +28 +27%
SIM
143
Sonora Investment Management
Arizona
$1K – – –
IA
144
IFP Advisors
Florida
$1K +$548 +45 New
AA
145
AlphaCentric Advisors
Puerto Rico
$1K +$1.22K +100 New
APA
146
American Portfolios Advisors
New York
$706 +$731 +60 New
Millennium Management
147
Millennium Management
New York
$309 -$2.07M -169,546 -87%
Handelsbanken Fonder
148
Handelsbanken Fonder
Sweden
– -$6.5M -440,551 Closed
CCM
149
CAAS Capital Management
New York
– -$4.05M -274,448 Closed
AAP
150
Ardsley Advisory Partners
Connecticut
– -$3.84M -260,000 Closed
3 4 5
6
7

AERI Hedge Fund Activity: Q3 2020 in Review

148 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Aerie Pharmaceuticals (AERI) for Q3 2020, worth a combined $552M — down 23% from $712M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of AERI and 16 opened new positions — a net loss of 6 holders — while 50 trimmed existing stakes and 50 added.

The largest buyer was C WorldWide Group, adding an estimated $11M. The largest seller was Citadel Advisors, cutting an estimated $10.4M.

  • 148 institutional investors held Aerie Pharmaceuticals (AERI) as of Q3 2020, down from 155 in Q2 2020.
  • Funds reported $552M of Aerie Pharmaceuticals stock for Q3 2020, down 23% quarter-over-quarter.
  • 16 funds opened new Aerie Pharmaceuticals positions in Q3 2020 and 22 closed out, a net change of -6 holders.
  • The largest Aerie Pharmaceuticals buyer in Q3 2020 was C WorldWide Group, an estimated $11M added.
  • The largest Aerie Pharmaceuticals seller in Q3 2020 was Citadel Advisors, an estimated $10.4M sold.

Based on aggregated 13F filings for Q3 2020.